Sinolink Securities has released a report indicating a rapid acceleration in the robotics industry's growth trajectory. UBTECH ROBOTICS has achieved global leadership in both revenue and sales volume for full-size humanoid robots, with Zhiyuan marking the production of its 10,000th general-purpose embodied robot. 2026 is identified as a critical inflection point for the humanoid robot sector's transition from concept to commercialization. The Tesla supply chain is expected to complete construction of large-scale production lines by the first half of 2026, with mass production commencing in August 2026. Leading domestic manufacturers are projected to scale annual shipments from thousands to tens of thousands of units, primarily for applications such as secondary development, guided tours, and inspection services. The current phase is characterized by consolidation in supply chains and technology among industry leaders, heralding a global "arms race" in robotics. The report highlights five key investment areas.

UBTECH ROBOTICS's 2025 performance report secured four global top positions in the humanoid robot sector. The company reported total revenue of RMB 2.001 billion, a 53.3% year-on-year increase, ranking first globally among humanoid robot enterprises. Gross profit reached RMB 750 million, surging 101.5% annually, indicating significantly enhanced profitability. The full-size embodied intelligent humanoid robot business was particularly outstanding, generating revenue of RMB 820 million, a dramatic increase of 2203.7% year-over-year, with sales of 1,079 units, up 35866.7%. This performance secured the global top spot in both revenue and volume for this category. Sales of non-full-size humanoid robots reached 12,759 units, also ranking first worldwide. The humanoid robot business now constitutes 41.0% of total revenue, becoming the company's largest income source for the first time, with over 80% of deployments in industrial settings like automotive manufacturing, leading global commercialization efforts.

Xinghai Tu completed a B+ funding round of RMB 2 billion, achieving a post-money valuation exceeding RMB 20 billion and topping the valuation charts for embodied AI companies in the primary market. The investor consortium included industrial giants, long-term primary and secondary funds, state-backed funds, and leading private equity firms. This strong backing provides substantial capital and builds significant industrial synergy and resource support. The company's valuation doubled within two months, driven by increased R&D investment, breakthroughs in open-source models, and market revaluation of the稀缺 value of core embodied AI "brain" technologies, providing a solid foundation for future foundational model development and real-world application deployment.

Zhiyuan Robot officially下线 its 10,000th general-purpose embodied robot, transforming its ten-thousand-unit scale manufacturing capability into a core competitive advantage. Breakthroughs in mass production have led to substantial purchase orders from industries such as automotive manufacturing, 3C electronics, and logistics warehousing. Market demand has shifted from initial trial phases to large-scale, essential deployments. Furthermore, Zhiyuan has partnered with The Chinese University of Hong Kong to establish a joint industry-academia research platform for embodied AI, focusing on advanced research in large models and talent cultivation, thereby bridging fundamental research with industrial application.

Dongfang Precision, in collaboration with Leju Robot, has officially launched China's first humanoid robot production line with an annual capacity of ten thousand units. This production line can produce one robot every 30 minutes. It encompasses 24 precision assembly processes and 77 comprehensive inspection points, utilizing full digital management to boost production efficiency by 50% compared to traditional methods. The line includes 41 simulated working condition tests to ensure product consistency and reliability. Its flexible, highly adaptable design allows for adjustable workstations and mixed-model production, supported by intelligent warehousing and AGV automated distribution systems, significantly enhancing overall operational efficiency.

Lingsheng Technology has introduced the LivUMI data collection solution, priced at around ten thousand RMB, addressing three major industry challenges: high costs, difficult adaptation, and low efficiency. Based on a "human-centric collection" philosophy, its lightweight handheld design overcomes the limitations of traditional motion capture studios and dedicated labs, enabling flexible data acquisition in fragmented scenarios like industrial production lines and home environments. Leveraging technical advantages such as millisecond-level multi-sensor hardware synchronization and micron-level gripper detection accuracy, along with full-platform robot compatibility and end-to-end data management capabilities, the solution significantly lowers the industry's technical entry barrier with exceptional cost-effectiveness.

The global landscape is evolving into a robotics "arms race," with five key focus areas identified: (1) Consolidation of the Tesla supply chain, which has iterated for four years and is nearing an inflection point of hardware supply chain stabilization. Focus on companies like Tuopu Group and Sanhua Intelligent Controls for their certainty and growth potential. (2) Technological iteration and convergence, favoring new electric drive technologies, dexterous hands, new materials like PEEK, and high-end bearings. (3) Opportunities in other overseas supply chains as companies like Apple, Google, OpenAI, and Figure advance from 0 to 1; focus on Yinlun Co., Ltd. and related electronic chain opportunities. (4) Opportunities in domestic robot本体 and vertical applications, with companies like Yushu, Zhiyuan, Leju, and Yinhe Tongyong approaching listings; monitor supply chain and本体 players such as Xianglou New Materials and Kelishi Sensing. (5) Investing in companies with "high-quality structures" for long-term certainty, with a focus on Orbbec.

Risk warnings include intensifying industry competition, potential underperformance in automotive and electric vehicle sales, and slower-than-expected progress in humanoid robot development.